AI-Generated Summaries for Eye Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment AI-Generated Plain Language Summaries for eye disease?
How is the AI-Generated Plain Language Summaries treatment different from other treatments for eye disease?
The AI-Generated Plain Language Summaries treatment is unique because it uses artificial intelligence to create easy-to-understand summaries of complex medical information, helping patients better understand their eye conditions and treatments. This approach differs from traditional treatments that focus on medical interventions, as it aims to improve patient comprehension and engagement.678910
What is the purpose of this trial?
This clinical trial is testing whether plain language summaries made by artificial intelligence help people understand their eye doctor's notes better. Adults receiving eye care at the Jules Stein Eye Institute will get either the usual medical notes or a note with the addition of an AI-generated summary that explains the information in simple, everyday words. Participants will then answer a short survey and receive a follow-up call to share how clear the information was, how well they understood their diagnosis and treatment, and whether they feel more confident about their care. The goal is to find out if these plain language summaries can make it easier for people to understand their eye care and improve communication between patients and health care providers.
Research Team
Prashant Tailor, MD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for English-speaking adults who are receiving eye care at the Jules Stein Eye Institute. It's designed to help those who may struggle with understanding medical jargon, possibly including patients with aphasia or other communication difficulties.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either standard ophthalmology notes or notes with an AI-generated plain language summary
Immediate Post-Visit Assessment
Participants complete a survey to assess comprehension and satisfaction immediately after their clinic visit
Follow-up
Participants receive a follow-up telephone interview to assess retention of information and provide additional feedback
Treatment Details
Interventions
- AI-Generated Plain Language Summaries
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor